Jack W. Singer, EVP, Chief Medical Officer at CELL THERAPEUTICS INC (CTIC), sold 1,520 shares at $0.13 ($198) on 2009-01-05, disclosed to the SEC on 2009-01-06.
Scheduled sale ($198) by EVP, Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CTIC | SELL | 2015-12-18 | $18K | — | Filing → |
| CTIC | SELL | 2015-11-30 | $18K | — | Filing → |
| CTIC | SELL | 2015-10-23 | $24K | — | Filing → |